从康复者双抗原特异性B细胞生成的针对SARS-CoV-2的强效中和性宽谱抗体

Masaru Takeshita1, Hidehiro Fukuyama2,3,4,5, Katsuhiko Kamada6

  • 1Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo 160-8582, Japan.

iScience
|June 8, 2023
PubMed
概括

研究人员开发了针对SARS-CoV-2变种的广泛中和抗体. 这些抗体在临床前模型中显示出治疗潜力,降低了感染仓鼠的病毒载量.